Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-28 @ 9:56 PM
Study NCT ID:
NCT05704933
Status:
COMPLETED
Last Update Posted:
2025-10-20
First Post:
2023-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-20
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-20
First Submit QC Date:
None
Study First Post Date:
2023-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-16
Last Update Post Date:
2025-10-20
Last Update Post Date Type:
ESTIMATED